ampio pharmaceuticals stock target price

AMPE was reported by Alliance Global Partners on Thursday March 24 2022. This is not a prediction by.


Ampio Pharmaceuticals Inc Ampe Stock Price Quote News Stock Analysis

Titan Pharmaceuticals Trading Down 24.

. The latest price target for Ampio Pharmaceuticals OTCPK. 2 days agoThey issued a buy rating and a 1600 price target for the company. RVPH stock opened at.

JPMorgan Chase Co. The businesss 50-day moving average price is 115 and its two-hundred day moving average price is 097. The analyst firm set a price target for 450.

Analyst ratings historical stock prices earnings estimates actuals. Stock Price Forecast The 1 analysts offering 12-month price forecasts for Ampio Pharmaceuticals Inc have a median target of 200 with a high estimate of 200 and a low estimate of 200. The current price Ampio Pharmaceuticals AMPE is trading at is 002 which is within the analysts predicted range.

Ampio Pharmaceuticals stock forecast analyst price target predictions based on 1 analysts offering 12-months price targets for DEAPH in the last 3 months. Reviva Pharmaceuticals Price Performance. AMPE analyst stock forecast price target and recommendation trends with in-depth analysis from research reports.

Stock Price Forecast According to 6 stock analysts the average 12-month stock price forecast for AMPE stock is 204 which predicts an increase of 61963. Stock Price Target AMPE. Rooms Rankings Earnings Newsletters.

Price Target Only one analyst offered a short-term price target of 300 for Ampio Pharmaceuticals. The current projected Ampio Pharmaceuticals target price. UK Stock Market Overview.

This represents an increase of 9 from the last closing price of 003. Find the latest Ampio Pharmaceuticals Inc. Get Reviva Pharmaceuticals alerts.

Real-time trade and investing ideas on Ampio Pharmaceuticals Inc AMPE from the largest community of traders and investors. In predicting price targets of as low as 1300 and as high as 3000 analysts are in agreement on assigning the stock over the next 12 months average price target of 2131. Stock quote stock chart quotes analysis advice financials and news for share AMPIO PHARMACEUTICALS INC.

Ampio Pharmaceuticals stock forecast analyst price target predictions based on 1 analysts offering 12-months price targets for AMPE in the last 3 months. Cut their price target on Alnylam Pharmaceuticals from 20400 to 20000 and set a neutral rating on the stock in a report on Monday October 24th. Browse analyst ratings and price targets on all stocks.

Analysts consensus targets ratings and recommendations Nyse. The target price for AMPE stock is 250 based on the average of what a group of analyst think AMPE stock could be worth at a future date. Ampio Pharmaceuticals AMPE PT Lowered to 2 at Roth Capital Roth Capital analyst Jonathan Aschoff lowered the price target on Ampio Pharmaceuticals NYSE.

AMPE to 200 from. The current analyst and expert consensus on Ampio Pharmaceuticals is Strong Buy with 0 strong sell and 1 strong buy opinions.


Ampio Pharmaceuticals Ampe 52 Week High At 1 71 Low At 0 02


Google News Search


3 Top Penny Stocks For Your December 2020 Watch List


Ampio Pharmaceuticals Fires Two Executives After Investigation Marketscreener


Is Ampio Pharmaceuticals Inc Ampe Stock A Good Value


Ampio Pharmaceuticals Inc Ampe Stock Price Quote News Stock Analysis


Ampio Pharmaceuticals Inc Ampe Stock Do Analysts Think You Should Hold


38 Collective Loss Ampe Stock Ampio Pharmaceuticals Securities Class Action Lawsuit Ampe Youtube


Buy Ampio Pharmaceuticals Stock Ampe Stock Price Today News Public Com


Transat A T Tse Trz Stock Price Crosses Below Fifty Day Moving Average Of 3 13 Defense World


Top Stocks To Watch Today Thursday September 16 Timothy Sykes


6 Penny Stocks With 1 000 Upside Potential Investorplace


What Are Some Stocks Under 500 Which I Can Buy For 10 Years Quora


Buy Ampio Pharmaceuticals Stock Ampe Stock Price Today News Public Com


Ampio Pharmaceuticals Crunchbase Company Profile Funding


Amgn 3 Biotech Stocks That Ll Make You Richer And 1 That Won T


Deja Vu Ampio S Stock Sinks As Fda Rejects Covid 19 Ravaged Osteoarthritis Trial Fierce Biotech


Why Ampio Pharmaceuticals Stock Is Rising Today Ampio Pharmaceuticals Otc Ampe Benzinga


Ampio Routed As Lead Osteoarthritis Drug Flunks A Phiii Test Fierce Biotech

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel